Recent developments with Annovis Bio Inc (ANVS) have led to the company’s beta value being reach 1.43 cents.

Shaun Noe

On Friday, Annovis Bio Inc (NYSE: ANVS) was 3.66% up from the session before settling in for the closing price of $4.92. A 52-week range for ANVS has been $1.11 – $7.39.

It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -73.95%. When this article was written, the company’s average yearly earnings per share was at 42.00%. With a float of $22.39 million, this company’s outstanding shares have now reached $26.50 million.

Annovis Bio Inc (ANVS) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Annovis Bio Inc stocks. The insider ownership of Annovis Bio Inc is 15.47%, while institutional ownership is 11.40%. The most recent insider transaction that took place on Nov 24 ’25, was worth 159,886. In this transaction Director of this company bought 39,200 shares at a rate of $4.08, taking the stock ownership to the 2,519,739 shares. Before that another transaction happened on Nov 21 ’25, when Company’s Director bought 20,000 for $3.50, making the entire transaction worth $69,900. This insider now owns 2,490,539 shares in total.

Annovis Bio Inc (ANVS) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 42.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.51% during the next five years compared to -73.95% drop over the previous five years of trading.

Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators

You can see what Annovis Bio Inc (ANVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.60. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.40 in one year’s time.

Technical Analysis of Annovis Bio Inc (ANVS)

The latest stats from [Annovis Bio Inc, ANVS] show that its last 5-days average volume of 2.37 million was superior to 0.79 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 88.75%.

During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 89.82%, which indicates a significant increase from 88.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.57 in the past 14 days, which was higher than the 0.22 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.44, while its 200-day Moving Average is $2.24. Now, the first resistance to watch is $5.43. This is followed by the second major resistance level at $5.77. The third major resistance level sits at $6.03. If the price goes on to break the first support level at $4.83, it is likely to go to the next support level at $4.57. The third support level lies at $4.23 if the price breaches the second support level.

Annovis Bio Inc (NYSE: ANVS) Key Stats

There are 26,503K outstanding shares of the company, which has a market capitalization of 135.16 million. As of now, sales total 0 K while income totals -24,590 K. Its latest quarter income was 0 K while its last quarter net income were -7,260 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.